The Enterprise Value as of September 2024 (TTM) for PLx Pharma Inc. (PLXP) is -66857020.00

According to PLx Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -66857020.00. This represents a change of -214.18% compared to the average of 58.55M of the last 4 quarters.

PLx Pharma Inc. (PLXP) Historical Enterprise Value (quarterly & annually)

How has PLXP Enterprise Value performed in the past?

The mean historical Enterprise Value of PLx Pharma Inc. over the last ten years is 49.94M. The current -66857020.00 Enterprise Value has changed -13488.79% with respect to the historical average. Over the past ten years (40 quarters), PLXP's Enterprise Value was at its highest in in the September 2021 quarter at 436.84M. The Enterprise Value was at its lowest in in the September 2022 quarter at -7241773.10.

PLx Pharma Inc. (PLXP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PLx Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PLx Pharma Inc. (PLXP) Average Enterprise Value

How has PLXP Enterprise Value performed in the past?

The current Enterprise Value of PLx Pharma Inc. (PLXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PLx Pharma Inc. (PLXP) Enterprise Value vs. Peers

How is PLXP’s Enterprise Value compared to its peers?

PLx Pharma Inc.’s Enterprise Value is less than Biofrontera Inc. (3.21M), less than Guardion Health Sciences, Inc. (2.19M), less than Shuttle Pharmaceuticals Holdings, Inc. (3.88M), less than Akanda Corp. (6.01M), less than China Pharma Holdings, Inc. (6.36M), less than Cann American Corp. (1.26M), less than Acorda Therapeutics, Inc. (187.38M), less than Kala Pharmaceuticals, Inc. (10.25M), less than Mallinckrodt plc (2.62B), less than Halo Collective Inc. (15.22M), less than Alimera Sciences, Inc. (363.67M), less than China SXT Pharmaceuticals, Inc. (-7431090.00), less than Petros Pharmaceuticals, Inc. (3.44M), less than Societal CDMO, Inc. (189.40M), less than Organogenesis Holdings Inc. (347.97M), less than Lifecore Biomedical, Inc. (269.28M), less than OptiNose, Inc. (178.29M),

Build a custom stock screener for PLx Pharma Inc. (PLXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PLx Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PLx Pharma Inc. (PLXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PLx Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.